California - I think the best way to describe how California will review SGUL-Nicosia is in terms of maintaining California approval rather than seeking California approval. Of course SGUL has been approved in California since they began looking at international schools. Now SGUL simply needs to go through the same process that Duke, Cornell and other well-established medical schools have done in regards to California reviewing our new campus in Cyprus. The best indications of how this should go can be found with GMC's validation process and how California has viewed other, similar programs.
New York - Frankly I don't think any other schools are going to be added to this list until NYS figures out how they want to treat this issue. NY schools reacted very aggressively with HHC's exclusive agreement. The whole debacle at Wyckoff through flames onto the fire. Until this commission NYS has set up comes up with a determination on how they will administer "approving" medical schools going forward, I think we can safely assume no new visits will be made and no new schools added. So for SGUL-Nicosia students we are in the process of finalizing clinical affiliations in Cyprus which takes away the "no more than 12 weeks of rotates outside the country where the school is domiciled" threat for denying Residency or Licensure applications.
New Jersey - Not going to happen and don't need it anyway. NJ approval is only for clinicals anyway so it affects non-NJ approved schools only by denying them access to rotations in NJ. No effect on the ability to gain Residency or Licensure for non-NJ approved schools.
Florida - Similar to NJ. Only limits access to rotations. No limits on Residency or Licensure.
Texas - Only comes when an alumnus applies for licensure and demonstrates equivilency to TX medical school educational standards. Not really an approval process for schools at all except of course in judging the quality of its alumni when they begin applying for Licensure in Texas.